Genomics England's priorities announced on 65th anniversary of the UK's NHS
The chief executive of the Association of the British Pharmaceutical Industry (ABPI) has welcomed the launch of Genomics England on the 65th anniversary of the UK’s National Health Service (NHS) today (July 5).
Last year Prime Minister David Cameron announced that the personal DNA of up to 100,000 patients or infections in patients will be sequenced over the next five years. Health Secretary Jeremy Hunt said today that based on expert scientific advice, it has initially prioritized sequencing of lung and pediatric cancer, rare diseases and infectious diseases.
The project will be run by Genomics England, an organization entirely owned by Department of Health (DH). Genomics England will manage contracts for specialist UK-based companies, universities and hospitals to supply services on sequencing, data linkage and analysis.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze